Reimbursement Submissions

(PBAC, MSAC, LSDP, PL)

 

 

Our expertise includes:

  • Health Technology Assessments (HTA)
  • PBAC Submissions
  • MSAC Submissions
  • PHARMAC Submissions
  • Prescribed List (formerly known as the Prosthesis List) Applications
  • Hospital Formulary Submissions:

    – Pricing and Reimbursement Strategy

    – Risk Sharing Agreements

    – Post-Market Analyses

    – Price/Volume Impact Analyses

    – Reimbursement Feasibility Studies

     

    Let us help you navigate the complexities of the Australian reimbursement landscape and achieve your market access goals.

    Get in touch with us today to discover how we can help your pharmaceuticals, biotech products, medical devices, and technologies successfully enter the Australian market.

    An IQVIA Business

    Contact Us

    IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations. Learn more at www.iqvia.com

    ADDRESS

    Level 8,141 Walker Street, North Sydney, NSW, 2060

    GET IN TOUCH

    2 + 3 =

    Privacy Policy

    Your Privacy Choices